LY3323795

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3323795, covering 2020-04-20 to 2020-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3323795 in Healthy Participants [Phase 1]